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Abstract 
Objective: The aim of this study was to investigate the homogeneity of the microvasculature 
of the subthalamic nucleus (STN) and to compare the STN’s vasculature between Parkinson’s 
disease (PD) patients and non-demented elderly. Studying the homogeneity of the STN’s 
vasculature can inform about whether the blood-oxygen level dependent (BOLD) signal used 
in functional magnetic resonance imaging (fMRI) could originate homogeneously from all 
putative STN parts.  
Methods: Immunohistochemistry with structural vasculature staining on post-mortem material 
of 6 Parkinson disease patients and 9 non-demented elderly was used to outline the 
microvasculature. Intensity measurements were performed for each STN in a central section 
and separately for the ventromedial and dorsolateral part, with two correlated outcome 
measures: the mean intensity and percentage stained.  
Results: No difference was found between the ventromedial and dorsolateral part of the STN 
for both outcome measures. Also, the intensity measurements of the central section of the 
STN did not differ between PD patients and non-demented elderly. 
Conclusions: This study did not find a difference in intensity of a structural vasculature 
staining within the STN. This could imply that all putative STN parts can provide equally 
strong BOLD signals. Future research should expand upon our findings with larger samples to 
further validate the use of BOLD fMRI to study neural activity in subcortical structures such 
as the STN and the processes behind the pathology and side effects of treatment in 
neurological disorders such as Parkinson’s disease. 
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Introduction 
Functional magnetic resonance imaging (fMRI) studies can be used to non-invasively 
investigate altered brain activity and structure in neurological disorders such as Parkinson’s 
disease (PD) (Boertien et al., 2011; Kahan et al., 2012; Prodoehl, Spraker, Corcos, Comella, 
& Vaillancourt, 2010). PD is a neurodegenerative disorder, characterized by motor symptoms 
such as resting tremor, bradykinesia, and rigidity (Cacabelos, 2017; Hirsch, Jette, Frolkis, 
Steeves, & Pringsheim, 2016). It is the second most prevalent neurodegenerative disorder 
after Alzheimer’s disease, with European prevalence rates ranging from 66 to 12,500 per 
100,000 and incidence rates from 5 to 346 per 100,000 (Von Campenhausen et al., 2005). The 
incidence of PD increases with age and is especially a burden on health care for countries 
with an increasing elderly population (Hirsch et al., 2016).  
  In PD, a selective loss of dopaminergic neurons in the substantia nigra (SN), which 
normally inhibit the subthalamic nucleus (STN), results in dysinhibition of the STN’s activity 
(Figure 1, p. 4). The STN is a small nucleus in the subcortex with sensorimotor, cognitive, 
and limbic functions, and part of the basal ganglia (Alkemade & Forstmann, 2014; 
Brunenberg et al., 2012; Temel, Blokland, Steinbusch, & Visser-Vandewalle, 2005). Thus, in 
PD the STN is overactivated, and then strongly excites the output nuclei of the basal ganglia. 
These output nuclei in turn inhibit the thalamus’ excitatory stimulation of the cortex more, 
leading to less excitation of the primary motor, premotor, and somatosensory cortex by the 
thalamus (Temel et al., 2005). This lower excitation is associated with PD’s sensorimotor 
problems (Bronstein et al., 2011; Fernández-Seara et al., 2015; Temel et al., 2005). 
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Figure 1. Adapted from Temel et al., 2005. In PD, the STN is overactive, leading to less excitation of the 
primary motor, premotor, and somatosensory cortex (c).  
 
  fMRI studies on PD suggest that deep brain stimulation (DBS) of the STN can 
normalize the altered activation patterns found in PD (Benabid, 2003; Hamani, Saint-Cyr, 
Fraser, Kaplitt, & Lozano, 2004; Hesselmann et al., 2004; Jech et al., 2001; Kahan et al., 
2012; Min et al., 2014; Phillips et al., 2006; Stefurak et al., 2003). However, the exact 
mechanisms behind the therapeutic effects of DBS are unclear (Kahan et al., 2012). A 
possible means by which DBS exerts its effects could be that it causes a depolarization block, 
by which it limits the occurrence of action potentials and thus neural activation (Beurrier, 
Bioulac, Audin, & Hammond, 2001). Also, DBS could lower neural activity by stimulating 
GABAergic afferents of the STN or other stimulated nuclei, which results in a release of 
GABA. This inhibitory neurotransmitter then hyperpolarizes postsynaptic terminals, thereby 
lowering the chances of action potentials occurring and consequently deactivating the 
stimulated nucleus (Moser, Gieselberg, Ro, Keller, & Qadri, 2003). Remarkably, it was found 
that high frequency DBS inhibits cell bodies of neurons by activating presynaptic terminals 
close to the electrode, but that it enhances output activity of a targeted nucleus by stimulating 
action potentials in the axons further away from the cell body (Grill & McIntrye, 2001; Grill, 
Snyder, & Miocinovic, 2004; Hashimoto, Elder, Okun, Patrick, & Vitek, 2003; McIntyre et 
al., 2004; Windels et al., 2003). This mechanism is different from the first two proposed in 
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which DBS has effects similar to a lesion (Temel et al., 2005). Moreover, many side effects 
are reported for DBS treatment of PD, with cognitive dysfunctions such as decreased verbal 
memory and executive functions mostly reported, followed by depression, occasionally 
accompanied by suicidal ideation (Brunenberg et al., 2012; Temel et al., 2005). These side 
effects might be caused by unintentional stimulation of putative non-sensomotoric parts of the 
STN (Alkemade, 2013; Plantinga et al., 2016; Temel et al., 2005). In sum, DBS is an effective 
technique for improving motor symptoms of PD, but its working mechanisms remain to be 
understood and side effects can be severe (Temel et al., 2005). 
  Studying the effects of DBS of the STN in PD or activity of subcortical structures such 
as the STN can be done with fMRI studies (Forstmann, de Hollander, van Maanen, 
Alkemade, & Keuken, 2017; Turner, 2016). fMRI measures the blood oxygen-level 
dependent (BOLD) signal, which increases with neural activity (Logothetis, 2008; Turner, 
2016). Neural activity is related to an increase in metabolic demand, which results in more 
oxygen extraction from the blood (Buxton & Frank, 1997; Gagnon et al., 2015; Hillman, 
2014). Dilation of arterioles and capillaries is thought to be caused by the molecules released 
during neural activity, usually overcompensating for the higher oxygen demands (Hall et al., 
2014; Hillman, 2014; Turner, 2016). This overoxygenation of the active region results in a 
decrease in deoxyhemoglobin (Hillman, 2014). Relating to deoxyhemoglobin’s paramagnetic 
properties which distort the magnetic field measured in fMRI, the BOLD signal increases 
with lower deoxyhemoglobin levels, thus with higher neural activity (Hillman, 2014). It was 
suggested that pericytes might be a crucial factor mediating the BOLD signal (Hall et al., 
2014; Hillman, 2014). Pericytes are contractile cells located in capillaries which regulate 
cerebral blood flow by dilating capillaries through relaxation during neural activity (Hall et 
al., 2014). Dilation of capillaries by pericytes was estimated to be responsible for as much as 
84% of the increase in blood flow following enduring neural activity by one study (Hall et al., 
2014). Neurovascular coupling might also be mediated by astrocytes, supporting cells located 
in between neurons and blood vessels (Hillman, 2014). An increase in glutamate, associated 
with neural activity, might be sensed by receptors on astrocytes which then initiate 
vasodilating processes (Hillman, 2014). However, recent findings have found the involvement 
of astrocytes in neurovascular coupling less likely than previously thought (Nizar et al., 
2013). Furthermore, interneurons have been proposed as an alternative mechanism involved 
in neurovascular coupling by releasing vasoactive substances (Cauli, 2004; Piché, Uchida, 
Hara, Aikawa, & Hotta, 2010). Last, vasodilation might be mediated by a part of the 
vasculature itself: the vascular endothelium, which lines the inner wall of all types of blood 
6 
 
vessels (Bagher & Segal, 2011; Figueroa & Duling, 2009; Wölfle et al., 2011). 
Hyperpolarisation can propagate along the endothelium, thereby self-initiating vasodilation. It 
was suggested that probably a combination of the described methods is responsible for the 
BOLD response (Attwell et al., 2010). In addition, the BOLD signal is criticized for not being 
spatially specific and an indirect measure of brain activity, the hemodynamic response lacking 
a few seconds behind actual neuronal activity (Hillman, 2014; Logothetis, 2008; Turner, 
2016). In short, the BOLD signal is probably mediated by several microvascular mechanisms 
involving the capillaries, but the contribution of each and the exact mechanism still needs to 
be ascertained. 
 Currently, it is unclear whether the just described BOLD signal used in fMRI studies 
in PD (e.g., Brunenberg et al., 2012) can provide insights into the internal structure of the 
STN. Studying the STN’s internal structure is relevant for successful DBS stimulation of the 
STN in PD: whether there are clear boundaries and subparts within the STN can influence the 
spreading of the DBS stimulation and therefore its planned and unintentional effects 
(Alkemade, 2013; de Hollander et al., 2014). The putative dorsolateral part of the STN, 
associated with sensorimotor functions, has been reported to be an effective target for DBS, 
lowering the sensorimotor problems often already seen early in PD (Bronstein et al., 2011; 
Fernández-Seara et al., 2015; Min et al., 2014; Plantinga et al., 2016). There is no consensus 
in the literature on the amount of anatomical subparts of the STN and on whether the potential 
boundaries between subparts are distinct or gradual (Alkemade & Forstmann, 2014; de 
Hollander et al., 2014; Keuken et al., 2012). The tripartite hypothesis seems most popular, 
dividing the STN into a dorsolateral sensorimotor part, a limbic part in the medial tip, and a 
central cognitive part (Parent & Hazrati, 1997; Temel et al., 2005), but this idea has been 
substantially opposed by others due to unconvincing evidence in favour of this hypothesis 
(Alkemade & Forstmann, 2014; de Hollander et al., 2014; Keuken et al., 2012). 
  To determine whether the BOLD signal can be informative about the internal structure 
of the STN, it needs to be ascertained whether the BOLD signal could homogeneously 
originate from the STN, in other words, whether all putative parts of the STN have a similar 
amount of local blood flow and can, in theory, provide equally strong BOLD signals. This is 
especially relevant with the increasing availability of ultra-high field (UHF) 7T MRI, enabling 
visualization of subcortical structures such as the STN which is difficult at lower field 
strengths (Forstmann et al., 2017; Turner, 2016). Little research has been conducted on the 
vasculature of the STN, but one previous study found increased blood flow within the STN in 
the direction of the SN (Wårdell, Hemm-Ode, Rejmstad, & Zsigmond, 2016). In addition, 
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higher density of markers in the ventromedial tip of the STN was reported (Alkemade, 
Balesar, Zhao, Swaab, & Forstmann, n.d.; Foix & Nicolesco, 1925; Fussenich, 1967; 
Kodama, 1928), which might translate into higher cell density in the ventromedial tip and 
heterogeneous vessel density across the STN. 
  To our knowledge, a study in which the main aim is to investigate the homogeneity of 
the vasculature of the STN has not been conducted before. A heterogeneous vasculature 
would indicate that all putative STN parts might not be able to provide equally strong BOLD 
signals. Then, fMRI BOLD studies might not be a valid method for studying neural activity in 
the STN, relevant for studies on DBS in PD or any other studies targeting potential 
subdivisions of the STN. In addition, comparing the STN’s vasculature between PD patients 
and non-demented elderly could associate structural vascular pathology within the STN with 
PD. Again, preceding research is limited, and to our knowledge, this study is the first using 
structural markers visualizing the STN’s vasculature. Nevertheless, one study found the 
number of capillaries to be smaller in PD patients than in non-demented elderly in the SN 
(Guan et al., 2013), a subcortical structure related to and proximal to the STN (Mai, Majtanik, 
M., & Paxinos, 2015).  
 This study aimed to investigate the vasculature of the STN up to the small-scale level 
of capillaries, from which the BOLD signal might originate, by using immunohistochemistry 
on human post-mortem material. First, the homogeneity of the STN’s vasculature was 
investigated, to determine whether the BOLD signal could originate homogeneously from all 
putative STN parts. Based on the few previous studies in which the internal structure of the 
STN was investigated, we expected the distribution of the vasculature marker within the STN 
to be heterogeneous, with an increased intensity in the direction of the ventromedial tip 
(Alkemade et al., n.d.; Fussenich, 1967; Kodama, 1928; Wårdell et al., 2016). Second, we 
aimed to compare the STN’s vasculature between PD patients and non-demented controls, 
possibly providing insight into the anatomy of the pathology of PD as suggested in a previous 
study (Plantinga et al., 2016). Based on the single study that found a smaller number of 
capillaries in PD patients than in non-demented elderly (Guan et al., 2013), the 
immunoreactivity to the vasculature marker in the STN was expected to be lower in PD 
patients than in non-demented elderly. 
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Methods 
Design & Participants 
  For this study, 15 post-mortem brains were studied, of which 6 from PD patients (3 
female, 3 male) and 9 from non-demented controls (4 female, 5 male). The post-mortem 
tissue blocks were obtained from the Netherlands Brain Bank, Amsterdam. PD patients were 
included if PD was diagnosed clinically in vivo according to standard clinical guidelines. The 
non-demented controls registered voluntarily at the Netherlands Brain Bank to donate their 
brains to research after death. Neuropathological examination post-mortem confirmed their 
non-demented status. Medical history was collected by reviewing patients’ clinical records. 
All material was obtained in accordance with ethical and legal guidelines of the Netherlands 
Brain Bank, ensuring informed consent and medical confidentiality. 
Procedure  
  The brains were dissected at autopsy and fixed in 10% phosphate-buffered formalin at 
room temperature. First, multimodal structural MRI scans using a 7T Magnetom MRI system 
were performed with the tissue blocks (see Figure 3 in Forstmann et al., 2017 and Weiss et al., 
2014 for the post-mortem data acquisition pipeline). Then, the tissue blocks were dehydrated 
and embedded in paraffin for conservation of the post-mortem material (see Figure 2 for an 
example of a tissue block). The tissue blocks were serially cut, rostral to caudal, on a 
microtome at 6 μm prior to block face imaging and 2D staining. This resulted in on average 
about 2000 sections per STN. Nissl staining was carried out on every 50
th
 section, for 
anatomical orientation. Block face imaging was performed on the Nissl stained sections after 
glass cover slipping the sections.  
  For the immunohistochemistry used in this study, 25 to 30 sections per person were 
obtained of the STN, spaced 300 μm apart. 2D immunocytochemical staining was performed 
with CD34 on consecutive sections. CD34 is a glycoprotein, found on hematopoietic 
progenitor cells and the endothelium of small blood vessels, and its function remains unclear 
(Satterthwaite, Burn, Le Beau, & Tenen, 1992; Simmons, Satterthwaite, Tenen, & Seed, 
1992). Since CD34 is present in the endothelium, it can be visualized using antibodies post-
mortem, demonstrating the vasculature. The primary antibody was mouse monoclonal anti-
CD34 (cat. no.sc-52312, lot. no. J2512, Santa Cruz, 1:50), the secondary antibody 
biotinylated anti-mouse IgG (1:400). Staining was amplified using the ABC vector elite kit. 
After completion of staining, sections were cover slipped, and digital images were obtained 
from the 2D stained sections. Then, these images of the stained tissue were brought together 
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in a common space with the block face images, allowing us to locate the STN in our images. 
Linear transformations were performed to register the images of the stained tissue to the 
corresponding block face images.  
 
Figure 2. Example of a tissue block. The drawing indicates that the left side of the block is the rostral side, the 
bottom ventral. 
 
Measures  
  Fiji, a distribution of ImageJ2 developed for analysing biological images, an open 
source Java image processing program, was used to perform densitometry on the stained 
image data (Abràmoff, Magalhães, & Ram, 2004; Schindelin et al., 2012). After thresholding 
the images, intensity measurements were done for each section. Intensity measurements of the 
ventromedial and dorsolateral part of the STN per participant for approximately each middle 
section along the rostro-caudal axis were quantified in ImageJ2. The intensity values for each 
complete STN in the same middle section per subject enabled a comparison of the STN’s 
vasculature between the non-demented elderly and PD patients. 
Statistical analyses  
  The data were analyzed with Rstudio, version 1.0.143. A Student’s t-test compared 
age between the non-demented elderly and PD patients. Normality was tested with Shapiro-
Wilk tests (ɑ = 0.05) for both hypotheses. Some resulting p-values were larger than .1, which 
makes the approximation of the p-values unreliable: our sample is probably too small for the 
Shapiro-Wilk test to pick up deviations from normality (Royston, 1995). Therefore, and due 
to the low number of observations in our post-mortem sample, we decided to use non-
parametric tests, since those are more conservative than parametric tests. 
 The dependent variable for both hypotheses, indicating the intensity of the vasculature 
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marker, was measured with ImageJ with two variables: the mean intensity, which is the sum 
of the gray values of all the pixels within the STN divided by the total number of pixels in the 
STN and therefore a relative measure, and the percentage stained, which indicates the 
percentage of pixels in the STN that have been highlighted (Ferreira & Rasband, 2012). These 
two measures are thus highly related, and both were used to verify the outcomes. 
  For the first hypothesis, the distribution of the vasculature marker within the STN was 
tested by the Wilcoxon-Signed Rank test, first for all participants, and then for PD patients 
and non-demented elderly separately. Including all participants, the Pearson’s correlation of 
the mean intensity and percentage stained ventromedially and dorsolaterally were both 
calculated. The intensity of the vasculature marker was compared between the ventromedial 
and dorsolateral part of the STN. The Wilcoxon-Signed Rank test takes into account that the 
data used to test this hypothesis are matched: observations of the intensity of the vasculature 
marker in the ventromedial and dorsolateral part of the STN are not independent, since they 
were measured within the same STN per participant. The location within the STN, 
ventromedial or dorsolateral, was the independent variable, the intensity of the vasculature 
marker the dependent variable. This hypothesis was tested twice with both outcome measures. 
Thus, the null hypothesis was that there is no relation between the location within the STN 
and the intensity of vessels found. We expected this null hypothesis to be rejected. 
 For the second hypothesis, group differences between post-mortem material from PD 
and non-demented elderly were tested with Mann-Whitney U tests. A Pearson’s correlation 
between the mean intensity and percentage stained was calculated including all participants. 
The independent variable was group (PD or non-demented elderly), the dependent variable 
the vessel intensity in the STN, again tested twice with the mean intensity and percentage 
stained as outcome variables. Thus, the null hypothesis was that there is no relation between 
group (PD or non-demented elderly) and vessel intensity, and we expected this hypothesis to 
be rejected.  
Results 
Participant characteristics 
  The average age at death was 86.40 years (SD = 10.31) for the total sample, 83.67 
years (SD = 5.65) for the PD patients and 88.22 years (SD = 12.52) for the non-demented 
elderly. Age did not differ between PD patients and non-demented elderly (p = .37, W = 19) 
Further demographics of the participants can be found in Table 1.  
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Table 1  
Clinicopathological data per participant 
NBB Age 
(y) 
Sex Brain type PMD 
(h:m) 
Fix  
(days) 
Medical history 
12062 88 M Control 05:40 nd ischemic bowel rupture (COD), aortic 
stenosis, femoropopliteal bypass, 
hypercholesterolemia, cardiorenal 
syndrome, ischaemic cardiomyopathy, 
atrical fibrillation, ischeamic bowel 
rupture, braak 4, tauopathy 
12082 101 F Control 05:10 nd cachexia (COD), cataract, TIA, mitral 
valve insufficiency, osteoporosis, 
coxarthrosis, cachexia, kyfose, 
decubitus dehydration 
13054 91 F PD 04:40 56 pneumonia by advanced LBD (COD), 
6yPD, LBD, Braak 6 aSYN, 
pneumonia, obstipation, tremor and 
saccadic eye movements, urinary tract 
infection, exelon 9,5mg 1dd1, madopar 
125mg 2dd1, dopa aggrevated the 
symptoms, hip replacement 
13058 77 F PD 07:20 53 sepsis by urinary tract infection (COD), 
PD, 15y, sepsis, hypertension, 
pulmonary embolism, 4dd 
levo/carbi/entacapon 100/25/100 
13060 84 M PD 04:50 48 pneumonia (COD), severe decubital 
ulcer, LBD. PD/LBD, 7y pneumonia, 
hypertension, COPD, type 2 diabetes, 
cardiac failure, aneurysm, MI, 
cholecystectomy, 
hypercholesterolemia, dementia 
hypothyroidism, rivastigmine 3dd3m, 
diabetic gastroparesis, collum fracture 
13072 87 F PD 08:10 57 uremia by dehydration (COD), 35y PD, 
M Raynaud, left onset PD, biperidene 
1mg 1dd1, levodopa/benserazide 125 
mg 4dd1, braak 3, note that PD and 
Raynaud medications are often contra-
indicated, making titration difficult 
13077 86 M PD 04:10 57 respiratory insufficiency (COD), PD, 
18y, respiratory insufficiency, 
levo/carbidopa 125mg 7dd1, 
rivastigmine 13,3mg/h, cholesteatoma, 
presbyacusis, thalamic DBS 
13061 77 M PD 03:10 56 aspiration pneumonia (COD), 31y PD, 
‘95 left pallidotomy, ‘97 right 
pallidotomy, Levodopa/carbidopa 
125mg 5dd1, clozapine 100 mg 3dd1, 
apomorphine 25mg 1dd1, rivastigmine 
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9,5mg dd, tremor stiffness 
bradykinesia, left onset, 
hypersexuality, oral behavior, 2 sybs 
also affected, braak 6,, glaucoma, 
visual hallucinations 
13095 101 F Control 06:15 57 pneumonia (COD), cateract, uterus 
extirpation, cholecystectomy, DM2, 
coxarthrosis, spondylosis, 
conjunctivitis, angina pectoric, COPD, 
cataract, cardiac falure, bullous 
pemphigoid, aspiration pneumonia, 
braak 2 
14037 101 F Control 07:27 57 renal insufficiency (COD), cataract, 
atrial fibrillation, hip replacement, 
scoliosis, dicopathy, gasteroenteritis, 
urinary tract infection, renal 
insufficiency 
14051 92 M Control 07:45 57 cardiac failure (COD), hip 
replacements, DMII, COPD, cataract 
liver cirrhosis, ascites, decubitus, 
polyneuropathy, heart failure 
14069 73 M Control 04:25 56 pneumonia (COD), COPD, 
hypercholestoerolemia, atrial 
fibrillation, anrtofemoral bypass, 
PTCA, cataract, spondylodese, 
oesophagitis, pneumonia, prostate 
carcinoma, hyperthyroidism, decubitus  
15033 93 M Control 07:40 59 cardiac failure (COD), aortic stenosis, 
decompensatio cordis, macular 
degeneration, basal cell carcinoma  
15035 73 M Control 08:00 56 pneumonia (COD), cardiac failure, 
myelodysplastic syndrome, fungal 
infection  
15055 72 F Control 06:50 55 respiratory insufficiency (COD), polio, 
ovarium carcinoma, ileus, osteoporosis, 
polymyalgia 
Note. COD = cause of death, F = female, Fix = fixation duration, LBD = Lewy Body Dementia, M = male, NBB 
= Netherlands Brain Bank number, nd = no date, PD = Parkinson’s disease, PMD = post-mortem delay, TIA = 
transcient ischemic attack, y = years. 
 
Distribution of the vasculature marker within the STN 
  Including all participants, the mean intensity and percentage stained ventromedially 
correlated highly (r = .97, p < .001), as did the mean intensity and percentage stained 
dorsolaterally (r = .97 , p < .001), affirming the use of both as outcome variables to double-
check our results. The average mean intensity of the staining was ventromedially 4.70 (SD = 
1.94), and dorsolaterally 5.10 (SD = 2.11) (see Figure 3). The percentage stained was 
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ventromedially on average 32.19% (SD = 11.71), and dorsolaterally on average 33.52% (SD = 
11.90) (see Figure 4). The Wilcoxon-Signed Rank test showed no difference between the 
ventromedial and dorsolateral part of the STN for both the outcome variables mean intensity 
(p = .15, V = 34, 95% CI [-1.17, 0.15]) and percentage stained (p = .23, V = 38, 95% CI [-
5.67, 1.57).  
  When including only PD patients in the analysis, the mean intensity was 
ventromedially on average 3.74 (SD = 2.18) and dorsolaterally on average 3.93 (SD = 2.22). 
The percentage stained was ventromedially on average 26.68% (SD = 13.18) and 
dorsolaterally on average 26.79% (SD = 11.18). No difference was found both for the mean 
intensity (p = 1.00, V = 10, 95% CI [-2.41, 3.14]) and the percentage stained (p = 1.00, V = 
10, 95% CI [-12.48, 19.45]). Including only the non-demented elderly resulted in an average 
mean intensity ventromedially of 5.35 (SD = 1.56) and dorsolaterally of 5.87 (SD = 1.74). The 
percentage stained was ventromedially on average 35.86% (SD = 9.66) and dorsolaterally on 
average 38.01% (SD = 10.62). Again, no difference was found for the mean intensity (p = .07, 
V = 7, 95% CI [-1.17, .06]) and the percentage stained (p = .13, V = 9, 95% CI [-5.73, 1.09]).  
 
 
Figure 3. Mean CD34 staining intensity ventromedially and dorsolaterally within the STN of Parkinson’s disease 
patients and non-demented elderly. PD = elderly with Parkinson’s disease, CTRL = non-demented elderly. 
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Figure 4. Percentage staining by the CD34 staining of the ventromedial and dorsolateral part of the STN in 
Parkinson’s disease patients and non-demented elderly. PD = elderly with Parkinson’s disease, CTRL = non-
demented elderly. 
Vasculature marker in PD patients compared to non-demented elderly 
  The mean intensity and percentage stained of the middle section of the STN across all 
participants correlated highly (r = .97, p < .001), thus using both for double-checking the 
outcomes appears valid. The mean intensity of the staining was 5.48 (SD = 1.57) in the non-
demented elderly and 3.79 (SD = 2.01) in the PD patients (see Figure 5). The percentage 
stained was 36.39% (SD = 9.78) in the non-demented elderly and 26.58% (SD = 10.84) in the 
PD patients (see Figure 6). The Mann-Whitney U test showed no difference between the mean 
intensity of the staining of PD patients and non-demented elderly (p = .07, W = 43, CI = -.082 
to 3.78). For the percentage stained, also no difference was found between the two groups (p 
= .11, W = 41, CI = -3.75 to 22.15).  
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Figure 5. Boxplot of the mean intensity of the CD34 staining in the STN of non-demented elderly and elderly 
with Parkinson’s disease. CTRL = non-demented elderly, PD = elderly with Parkinson’s disease. 
 
 
Figure 6. Boxplot of the percentage stained of the STN with the CD34 staining of non-demented elderly and 
elderly with Parkinson’s disease. CTRL = non-demented elderly, PD = elderly with Parkinson’s disease.  
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Discussion 
This study aimed to investigate the vasculature of the STN with immunohistochemistry in 
human post-mortem material of PD patients and non-demented elderly. Our results showed no 
heterogeneous distribution of the structural vasculature marker within the STN: the 
ventromedial and dorsolateral part of the STN did not show different staining intensities. 
Further, no difference was found when comparing the staining intensity of a central section of 
each STN between PD patients and non-demented elderly. 
  The finding that the staining intensity did not differ between the ventromedial and 
dorsolateral part of the STN is contrary to our first hypothesis, and not in line with the few 
studies that pointed out a higher density of markers in the ventromedial part of the STN 
(Alkemade, Balesar, Zhao, Swaab, & Forstmann, n.d.; Foix & Nicolesco, 1925; Fussenich, 
1967; Kodama, 1928). However, the markers used in these previous studies were no specific 
structural vasculature markers, but protein markers that for example stain neuronal cell bodies 
(e.g. Alkemade et al., n.d.). Thus, the different findings might be explained by the different 
markers used. Our results are also different from one study that showed increased blood flow 
in the ventromedial part (Wårdell, Zsigmond, Richter, & Hemm, 2013). It has to be noted that 
Wårdell et al. (2013) used 1.5T and CT scans to locate the STN. The spatial resolution of 1.5T 
is too low a field strength to precisely delineate subcortical structures such as the STN 
(Forstmann et al., 2017; Turner, 2016). Therefore, we cannot be certain whether their reported 
increased blood flow in the direction of the SN is truly located in the ventromedial tip of the 
STN. Further, the microvascular blood flow measured by Wårdell et al. (2013) is a different 
method from our structural vasculature staining. Both are relevant for and might be related to 
the BOLD signal (Bagher & Segal, 2011; Hall et al., 2014), but measure different 
mechanisms that are probably not directly related. For example, pericytes might regulate local 
blood flow by dilating capillaries, in which the pericytes directly control the amount of blood 
flow, and the amount of capillaries only indirectly by providing the structure through which 
the blood flow can occur (Hall et al., 2014). For these reasons, our findings might not have 
been in line with those of Wårdell et al. (2013). Still, our results could indicate that the 
ventromedial and dorsolateral part of the STN might be able to provide equally strong BOLD 
signals. This is relevant for fMRI studies on PD, since our results do not invalidate fMRI 
BOLD as a method to study neural activity in the STN. Then, fMRI might be a valid method 
to study activity of possible subdivisions of the STN. However, studies with larger samples 
are recommended to establish this, and our results should be viewed as preliminary. 
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  Second, since the intensity of the vasculature staining in the STN did not differ 
between PD patients and non-demented elderly, our second hypothesis could not be 
confirmed. However, this hypothesis was based on only one previous study in the SN, and the 
influence of PD on the SN might be different from the STN, considering their different roles 
in the neuropathology of PD (Guan et al., 2013; Temel et al., 2005). Our results do not enable 
us to associate differences in structural vascular pathology of the STN between PD patients 
and non-demented elderly. It was already suggested that it is still unknown whether and which 
changes to the vasculature are a characteristic of PD (Guan et al., 2013). It might also be that 
our staining method cannot show the damage to the vasculature caused by PD. For instance, 
PD might shorten the length of capillaries or decrease capillary connections (Guan et al., 
2013), or could damage the microvasculature in another way that our structural marker might 
not have been able to capture. Further, it might be that the structural vasculature is not one of 
the main biomarkers affected by PD. Then, studying the structural vasculature of the STN 
might not be favourable for understanding the pathological mechanisms of PD. In sum, we 
cannot conclude that there is lower immunoreactivity to the vasculature marker in PD patients 
than in non-demented elderly. 
  Since our results do not show a difference in immunoreactivity to the vasculature 
marker between the dorsolateral and ventromedial part of the STN, this suggests the 
vasculature of the STN to be homogeneous. Then, the vasculature might not show clear 
boundaries within the STN according to our results, which could imply that the STN has no 
clear subdivisions, in line with the idea that the tripartite division of the STN should be 
revised (Alkemade & Forstmann, 2014; de Hollander et al., 2014; Keuken et al., 2012). Thus, 
since our results demonstrate no rigid boundaries, the STN might rather have a gradual 
topographical organisation than a distinct organisation, making prevention of side effects of 
STN DBS by accidentally stimulating putative untargeted subparts of the STN in PD difficult 
(Temel et al., 2005). Additionally, due to the increasing availability of UHF fMRI and thus 
improved visualization of the subcortex (Forstmann et al., 2017; Turner, 2016), it is of 
importance to know whether the measured BOLD signal originating from, for example, the 
STN can actually differentiate between subparts of the STN, this not being due to differences 
in vasculature between subparts of the STN. Since our results indicate the subparts to in 
theory be able to provide similar BOLD signals, this study supports the use of UHF fMRI to 
study neural activity in subparts of small subcortical structures. 
 Some limitations of this study should be mentioned. First of all, the small sample size 
limits the reach of our conclusions. Unfortunately, in post-mortem research, large sample 
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sizes are difficult to obtain and this limitation is rather inherent to this type of study. 
However, a solution for future research might be combining UHF MRI research and post-
mortem research by registering acquired images through these methods to the same common 
space, yielding the MRI and post-mortem images comparable (Forstmann et al., 2017). 
Consequently, since MRI images are relatively easier to collect than post-mortem images 
since they can be obtained in living persons, this would make the low sample sizes of post-
mortem research less problematic, and furthermore, the benefits of both methods could then 
be combined by their integration (Forstmann et al., 2017). Second, some of the participants 
showed comorbid Lewy Body Dementia which was confirmed by post-mortem pathological 
examination. Clinically, PD and variants of Lewy Body Dementia are difficult to differentiate 
(Gomperts, 2016). Due to the limited availability of post-mortem material and similar clinical 
presentations of PD and variants of Lewy Body Dementia in vivo we did not regard patients 
with Lewy Body Dementia as a separate group, which might have influenced our results. For 
instance, the STN hyperactivity typical of PD could be lower in patients with comorbid Lewy 
Body Dementia than in patients with only PD. Furthermore, all participants in this study were 
elderly with high medical comorbidity for which cannot be controlled. Therefore, it is difficult 
to ascertain whether our findings comparing the PD patients and non-demented elderly are 
due to their neurological state or whether other medical conditions were of significant 
influence. Additionally, the PD patients in our sample were slightly younger than the non-
demented elderly, which might have influenced our findings in comparing the two groups. 
Last, since the microvascular mechanisms behind the BOLD response are not understood yet 
(Hall et al., 2014; Hillman, 2014), we cannot be certain that the CD34 structural vasculature 
marker used in this study, present in the endothelium of small blood vessels, is directly related 
to the vasculature mechanisms behind the BOLD response. It was suggested that the vascular 
endothelium mediates vasodilation and plays a role in the BOLD response (Bagher & Segal, 
2011; Figueroa & Duling, 2009; Wölfle et al., 2011), but several other coupling mechanisms 
have also been suggested (Cauli, 2004; Hall et al., 2014; Hillman, 2014; Nizar et al., 2013; 
Piché et al., 2010). Thus, even though our results indicate that the ventromedial and 
dorsolateral part of the STN could provide equally strong BOLD signals, other studies using 
different vasculature markers and methods should confirm these results. In short, our results 
should be seen as a first indication that the structural vasculature of the STN might be 
homogeneous. 
 This study brought up some suggestions for further research. First, the vasculature of 
the STN could be measured in more than the two subparts we investigated. In our images, we 
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only measured the intensity of the staining in the ventromedial and dorsolateral part, and not 
in for example, the central part of the STN. Measuring the intensity of the staining in the 
ventromedial and dorsolateral part is namely more evident than measuring another part of the 
STN, because the ventromedial and dorsolateral part are at the STN’s extremes. Since there is 
no consensus on the amount of anatomical subparts of the STN (Alkemade & Forstmann, 
2014; Keuken et al., 2012), studying several subparts could support our finding that the 
vasculature appears homogeneous across the STN, indicating no rigid boundaries in the 
vasculature of the STN. Secondly, since we only measured the immunoreactivity in the 
middle section of the STN for each participant we recommend future studies to measure 
across the entire rostro-caudal axis. Studying the STN across its rostro-caudal axis would 
allow for measuring the length and change of shape of blood vessels throughout the STN. In 
addition, different structural vasculature markers could be used to support the current 
findings.  
  
Conclusions 
In conclusion, this study did not find a difference in intensity of a structural vasculature 
staining when comparing the dorsolateral and ventromedial part of the STN of PD patients 
and non-demented elderly. This might indicate that all putative STN parts can provide equally 
strong BOLD signals. Also, this could imply that at least in the structural vasculature the STN 
has no clear anatomical subdivisions, possibly making prevention of side effects to STN DBS 
challenging. Also, our results do not invalidate fMRI BOLD as a method to study neural 
activity in the STN. Secondly, no difference in vasculature staining was found between PD 
patients and non-demented elderly. We suggest future studies to expand upon our findings to 
further validate the use of BOLD fMRI to study neural activity in subcortical structures such 
as the STN and the processes behind the pathology and side effects of treatment in 
neurological disorders such as PD. 
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